Celiac disease

Current Opinion in Gastroenterology

Volumn 26, Issue 2, 2010, Pages 116-122

  Rubio Tapia, Alberto ^a   Murray, Joseph A ^a  

^a MAYO CLINIC   (United States)

Author keywords

Autoimmunity; Gluten; Mortality; Undiagnosed celiac disease

Indexed keywords

VITAMIN B GROUP;

CELIAC DISEASE; CLINICAL TRIAL; DIAGNOSTIC ACCURACY; DUODENUM BIOPSY; GENOME; GLUTEN FREE DIET; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; INTESTINE BIOPSY; INTESTINE ENDOSCOPY; MORTALITY; PATHOGENESIS; REVIEW; SEROLOGY; VITAMIN SUPPLEMENTATION;

ANIMALS; AUTOANTIBODIES; AUTOIMMUNE DISEASES; BIOPSY, NEEDLE; CELIAC DISEASE; DIET, GLUTEN-FREE; DISEASE MODELS, ANIMAL; ENDOSCOPY, GASTROINTESTINAL; FEMALE; FOLLOW-UP STUDIES; GLUTENS; HUMANS; INTESTINAL MUCOSA; INTESTINE, SMALL; MALE; MICE; PREVALENCE; RISK ASSESSMENT; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME;

EID: 77149132464     PISSN: 02671379     EISSN: None     Source Type: Journal    
DOI: 10.1097/MOG.0b013e3283365263     Document Type: Review

References (80)

1. Rubio-Tapia A, Kyle RA, Kaplan EL, et al. Increased prevalence and mortality in undiagnosed celiac disease. Gastroenterology 2009; 137:88-93.
2. Lohi S, Mustalahti K, Kaukinen K, et al. Increasing prevalence of coeliac disease over time. Aliment Pharmacol Ther 2007; 26:1217-1225.
3. Ivarsson A, Persson LA, Nystrom L, et al. Epidemic of coeliac disease in Swedish children. Acta Paediatr 2000; 89:165-171.
4. Olsson C, HernellO, Hornell A, et al. Difference in celiac disease risk between Swedish birth cohorts suggests an opportunity for primary prevention. Pediatrics 2008; 122:528-534.
5. Myleus A, Ivarsson A, Webb C, et al. Celiac disease revealed in 3% of Swedish 12-year-olds born during an epidemic. J Pediatr Gastroenterol Nutr 2009; 49:170-176.
6. Vilppula A, Kaukinen K, Luostarinen L, et al. Increasing prevalence and high incidence of celiac disease in elderly people: a population-based study. BMC Gastroenterol 2009; 9:49.
7. Virta LJ, Kaukinen K, Collin P. Incidence and prevalence of diagnosed coeliac disease in Finland: results of effective case finding in adults. Scand J Gastroenterol 2009; 44:933-939.
8. Kondrashova A, Mustalahti K, Kaukinen K, et al. Lower economic status and inferior hygienic environment may protect against celiac disease. Ann Med 2008; 40:223-231.
9. Cabrera-Chavez F, Rouzaud-Sandez O, Sotelo-Cruz N, Calderon de la Barca AM. Bovine milk caseins and transglutaminase-treated cereal prolamins are differentially recognized by IgA of celiac disease patients according to their age. J Agric Food Chem 2009; 57:3754-3759.
10. Abu-Zekry M, Kryszak D, Diab M, et al. Prevalence of celiac disease in Egyptian children disputes the east-west agriculture-dependent spread of the disease. J Pediatr Gastroenterol Nutr 2008; 47:136-140.
11. Johannsson GF, Kristjansson G, Cariglia N, Thorsteinsson V. The prevalence of celiac disease in blood donors in Iceland. Dig Dis Sci 2009; 54:348-350.
12. Metzger MH, Heier M, Maki M, et al. Mortality excess in individuals with elevated IgA antitransglutaminase antibodies: the KORA/MONICA Augsburg cohort study 1989-1998. Eur J Epidemiol 2006; 21:359-365.
13. Lohi S, Maki M, Montonen J, et al. Malignancies in cases with screeningidentified evidence of coeliac disease: a long-term population-based cohort study. Gut 2009; 58:643-647.
14. Lohi S, Maki M, Rissanen H, et al. Prognosis of unrecognized coeliac disease as regards mortality: a population-based cohort study. Ann Med 2009:1-8.
15. Lammers KM, Lu R, Brownley J, et al. Gliadin induces an increase in intestinal permeability and zonulin release by binding to the chemokine receptor CXCR3. Gastroenterology 2008; 135:194-204e3.
16. Matysiak-Budnik T, Moura IC, Arcos-Fajardo M, et al. Secretory IgA mediates retrotranscytosis of intact gliadin peptides via the transferrin receptor in celiac disease. J Exp Med 2008; 205:143-154.
17. Heyman M, Menard S. Pathways of gliadin transport in celiac disease. Ann N Y Acad Sci 2009; 1165:274-278.
18. Schumann M, Richter JF, Wedell I, et al. Mechanisms of epithelial translocation of the alpha(2)-gliadin-33mer in coeliac sprue. Gut 2008; 57:747-754.
19. Fina D, Sarra M, Caruso R, et al. Interleukin 21 contributes to the mucosal T helper cell type 1 response in coeliac disease. Gut 2008; 57:887-892.
20. Bas A, Forsberg G, Sjoberg V, et al. Aberrant extrathymic T cell receptor gene rearrangement in the small intestinal mucosa: a risk factor for coeliac disease? Gut 2009; 58:189-195.
21. Grose RH, Thompson FM, Cummins AG. Deficiency of 6B11+ invariant NK Tcells in celiac disease. Dig Dis Sci 2008; 53:1846-1851.
22. Tang F, Chen Z, Ciszewski C, et al. Cytosolic PLA2 is required for CTLmediated immunopathology of celiac disease via NKG2D and IL-15. J Exp Med 2009; 206:707-719.
23. Di Sabatino A, Rovedatti L, Rosado MM, et al. Increased expression of mucosal addressin cell adhesion molecule 1 in the duodenum of patients with active celiac disease is associated with depletion of integrin alpha4beta7- positive T cells in blood. Hum Pathol 2009; 40:699-704.
24. Ashorn S, Raukola H, Valineva T, et al. Elevated serum anti-Saccharomyces cerevisiae, anti-I2 and anti-OmpW antibody levels in patients with suspicion of celiac disease. J Clin Immunol 2008; 28:486-494.
25. Ashorn S, Valineva T, Kaukinen K, et al. Serological responses to microbial antigens in celiac disease patients during a gluten-free diet. J Clin Immunol 2009; 29:190-195.
26. Vivas S, Ruiz de Morales JM, Fernandez M, et al. Age-related clinical, serological, and histopathological features of celiac disease. Am J Gastroenterol 2008; 103:2360-2365; quiz 2366.
27. Ortega Paez E, Junco Lafuente P, Baca Garcia P, et al. Prevalence of dental enamel defects in celiac patients with deciduous dentition: a pilot study. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2008; 106:74-78.
28. Larsson K, Carlsson A, Cederwall E, et al. Annual screening detects celiac disease in children with type 1 diabetes. Pediatr Diabetes 2008; 9:354-359.
29. Ludvigsson JF, Olen O, Bell M, et al. Coeliac disease and risk of sepsis. Gut 2008; 57:1074-1080.
30. Thomas HJ, Wotton CJ, Yeates D, et al. Pneumococcal infection in patients with coeliac disease. Eur J Gastroenterol Hepatol 2008; 20:624-628.
31. Gao Y, Kristinsson SY, Goldin LR, et al. Increased risk for non-Hodgkin lymphoma in individuals with celiac disease and a potential familial association. Gastroenterology 2009; 136:91-98.
32. Hadjivassiliou M, Aeschlimann P, Strigun A, et al. Autoantibodies in gluten ataxia recognize a novel neuronal transglutaminase. Ann Neurol 2008; 64:332-343.
33. Neuhausen SL, Steele L, Ryan S, et al. Co-occurrence of celiac disease and other autoimmune diseases in celiacs and their first-degree relatives. J Autoimmun 2008; 31:160-165.
34. Rubio-Tapia A, Van Dyke CT, Lahr BD, et al. Predictors of family risk for celiac disease: a population-based study. Clin Gastroenterol Hepatol 2008; 6:983-987.
35. Garud S, Leffler D, Dennis M, et al. Interaction between psychiatric and autoimmune disorders in coeliac disease patients in the Northeastern United States. Aliment Pharmacol Ther 2009; 29:898-905.
36. Green PH, Yang J, Cheng J, et al. An association between microscopic colitis and celiac disease. Clin Gastroenterol Hepatol 2009; 7:1210-1216.
37. Frost AR, Band MM, Conway GS. Serological screening for coeliac disease in adults with Turner's syndrome: prevalence and clinical significance of endomysium antibody positivity. Eur J Endocrinol 2009; 160:675-679.
38. Rubio-Tapia A, Barton SH, Rosenblatt JE, Murray JA. Prevalence of small intestine bacterial overgrowth diagnosed by quantitative culture of intestinal aspirate in celiac disease. J Clin Gastroenterol 2009; 43:157-161.
39. Ford AC, Chey WD, Talley NJ, et al. Yield of diagnostic tests for celiac disease in individuals with symptoms suggestive of irritable bowel syndrome: systematic review and meta-analysis. Arch Intern Med 2009; 169:651-658.
40. Smyth DJ, Plagnol V, Walker NM, et al. Shared and distinct genetic variants in type 1 diabetes and celiac disease. N Engl J Med 2008; 359:2767-2777.
41. Trynka G, Zhernakova A, Romanos J, et al. Coeliac disease-associated risk variants in TNFAIP3 and REL implicate altered NF-kappaB signalling. Gut 2009; 58:1078-1083.
42. Garner CP, Murray JA, Ding YC, et al. Replication of celiac disease UK genome-wide association study results in a US population. Hum Mol Genet 2009; 18:4219-4225.
43. Romanos J, van Diemen CC, Nolte IM, et al. Analysis of HLA and non-HLA alleles can identify individuals at high risk for celiac disease. Gastroenterology 2009; 137:834-840.
44. Li M, Yu L, Tiberti C, et al. A report on the International Transglutaminase Autoantibody Workshop for Celiac Disease. Am J Gastroenterol 2009; 104:154-163.
45. Evans KE, Malloy AR, Gorard DA. Changing patterns of coeliac serology requests. Aliment Pharmacol Ther 2009; 29:1137-1142.
46. Prause C, Ritter M, Probst C, et al. Antibodies against deamidated gliadin as new and accurate biomarkers of childhood coeliac disease. J Pediatr Gastroenterol Nutr 2009; 49:52-58.
47. Rashtak S, Ettore MW, Homburger HA, Murray JA. Combination testing for antibodies in the diagnosis of coeliac disease: comparison of multiplex immunoassay and ELISA methods. Aliment Pharmacol Ther 2008; 28: 805-813.
48. Bonamico M, Nenna R, Luparia RP, et al. Radioimmunological detection of antitransglutaminase autoantibodies in human saliva: a useful test to monitor coeliac disease follow-up. Aliment Pharmacol Ther 2008; 28:364-370.
49. Naiyer AJ, Hernandez L, Ciaccio EJ, et al. Comparison of commercially available serologic kits for the detection of celiac disease. J ClinGastroenterol 2009; 43:225-232.
50. Hull CM, Liddle M, Hansen N, et al. Elevation of IgA antiepidermal transglutaminase antibodies in dermatitis herpetiformis. Br J Dermatol 2008; 159: 120-124.
51. Leong RW, Nguyen NQ, Meredith CG, et al. In vivo confocal endomicroscopy in the diagnosis and evaluation of celiac disease. Gastroenterology 2008; 135:1870-1876.
52. Cammarota G, Cesaro P, Cazzato A, et al. Optimal band imaging system: a new tool for enhancing the duodenal villous pattern in celiac disease. Gastrointest Endosc 2008; 68:352-357.
53. Pohl H, Rosch T, Tanczos BT, et al. Endocytoscopy for the detection of microstructural features in adult patients with celiac sprue: a prospective, blinded endocytoscopy-conventional histology correlation study. Gastrointest Endosc 2009; 70:933-941.
54. Bonamico M, Thanasi E, Mariani P, et al. Duodenal bulb biopsies in celiac disease: a multicenter study. J Pediatr Gastroenterol Nutr 2008; 47:618-622.
55. Vande Voort JL, Murray JA, Lahr BD, et al. Lymphocytic duodenosis and the spectrum of celiac disease. Am J Gastroenterol 2009; 104:142-148.
56. Biagi F, Bianchi PI, Campanella J, et al. The prevalence and the causes of minimal intestinal lesions in patients complaining of symptoms suggestive of enteropathy: a follow-up study. J Clin Pathol 2008; 61:1116-1118.
57. Tosco A, Maglio M, Paparo F, et al. Immunoglobulin A antitissue transglutaminase antibody deposits in the small intestinal mucosa of children with no villous atrophy. J Pediatr Gastroenterol Nutr 2008; 47:293-298.
58. Koskinen O, Collin P, Korponay-Szabo I, et al. Gluten-dependent small bowel mucosal transglutaminase 2-specific IgA deposits in overt and mild enteropathy coeliac disease. J Pediatr Gastroenterol Nutr 2008; 47:436-442.
59. Lanzini A, Lanzarotto F, Villanacci V, et al. Complete recovery of intestinal mucosa occurs very rarely in adult coeliac patients despite adherence to gluten-free diet. Aliment Pharmacol Ther 2009; 29:1299-1308.
60. Kurppa K, Collin P, Viljamaa M, et al. Diagnosing mild enteropathy celiac disease: a randomized, controlled clinical study. Gastroenterology 2009; 136:816-823.
61. Grodzinsky E, Falth-Magnusson K, Hogberg L, et al. IgA endomysium antibodies: an early predictor for celiac disease in children without villous atrophy. Acta Paediatr 2008; 97:972-976.
62. van Koppen EJ, Schweizer JJ, Csizmadia CG, et al. Long-term health and quality-of-life consequences of mass screening for childhood celiac disease: a 10-year follow-up study. Pediatrics 2009; 123:e582-e588.
63. Nachman F, Maurino E, Vazquez H, et al. Quality of life in celiac disease patients: prospective analysis on the importance of clinical severity at diagnosis and the impact of treatment. Dig Liver Dis 2009; 41:15-25.
64. Kaukinen K, Salmi T, Collin P, et al. Clinical trial: gluten microchallenge with wheat-based starch hydrolysates in coeliac disease patients: a randomized, double-blind, placebo-controlled study to evaluate safety. Aliment Pharmacol Ther 2008; 28:1240-1248.
65. Haines ML, Anderson RP, Gibson PR. Systematic review: the evidence base for long-term management of coeliac disease. Aliment Pharmacol Ther 2008; 28:1042-1066.
66. Leffler DA, Dennis M, Edwards George JB, et al. A simple validated gluten-free diet adherence survey for adults with celiac disease. Clin Gastroenterol Hepatol 2009; 7:530-536; 536.e1-536.e2.
67. Olsson C, Hornell A, Ivarsson A, Sydner YM. The everyday life of adolescent coeliacs: issues of importance for compliance with the gluten-free diet. J Hum Nutr Diet 2008; 21:359-367.
68. Olsson C, Lyon P, Hornell A, et al. Food that makes you different: the stigma experienced by adolescents with celiac disease. Qual Health Res 2009; 19:976-984.
69. Valerio G, Spadaro R, Iafusco D, et al. The influence of gluten free diet on quantitative ultrasound of proximal phalanxes in children and adolescents with type 1 diabetes mellitus and celiac disease. Bone 2008; 43:322-326.
70. Hallert C, Svensson M, Tholstrup J, Hultberg B. Clinical trial: B vitamins improve health in patients with coeliac disease living on a gluten-free diet. Aliment Pharmacol Ther 2009; 29:811-816.
71. Halfdanarson TR, Kumar N, Hogan WJ, Murray JA. Copper deficiency in celiac disease. J Clin Gastroenterol 2009; 43:162-164.
72. Kinsey L, Burden ST, Bannerman E. A dietary survey to determine if patients with coeliac disease are meeting current healthy eating guidelines and how their diet compares to that of the British general population. Eur J Clin Nutr 2008; 62:1333-1342.
73. Stevens L, Rashid M. Gluten-free and regular foods: a cost comparison. Can J Diet Pract Res 2008; 69:147-150.
74. Huibregtse IL, Marietta EV, Rashtak S, et al. Induction of antigen-specific tolerance by oral administration of Lactococcus lactis delivered immunodominant DQ8-restricted gliadin peptide in sensitized nonobese diabetic Abo Dq8 transgenic mice. J Immunol 2009; 183:2390-2396.
75. Pinier M, Verdu EF, Nasser-Eddine M, et al. Polymeric binders suppress gliadin-induced toxicity in the intestinal epithelium. Gastroenterology 2009; 136:288-298.
76. Stenman SM, Venalainen JI, Lindfors K, et al. Enzymatic detoxification of gluten by germinating wheat proteases: implications for new treatment of celiac disease. Ann Med 2009; 41:390-400.
77. Ehren J, Govindarajan S, Moron B, et al. Protein engineering of improved prolyl endopeptidases for celiac sprue therapy. Protein Eng Des Sel 2008; 21:699-707.
78. Rubio-Tapia A, Kelly DG, Lahr BD, et al. Clinical staging and survival in refractory celiac disease: a single center experience. Gastroenterology 2009; 136:99-107; quiz 352-353.
79. Malamut G, Afchain P, Verkarre V, et al. Presentation and long-term follow-up of refractory celiac disease: comparison of type I with type II. Gastroenterology 2009; 136:81-90.
80. Verbeek WH, von Blomberg BM, Coupe VM, et al. Aberrant T-lymphocytes in refractory coeliac disease are not strictly confined to a small intestinal intraepithelial localization. Cytometry B Clin Cytom 2009; 76:367-374.